(Q40015389)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Kwang-Kyu Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jung Joon Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Kwan-Hee You

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jeong-Hyung Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

6 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

704-712

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18258606%20AND%20SRC:MED&resulttype=core&format=json

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

PLAB, a novel placental bone morphogenetic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Autocrine human growth hormone inhibits placental transforming growth factor-beta gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Lysophospholipids transactivate HER2/neu (erbB-2) in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

mTOR, translation initiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

The Akt-mTOR tango and its relevance to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Placenta growth factor activates monocytes and correlates with sickle cell disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

PI3K is required for insulin-stimulated but not EGF-stimulated ERK1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031

Targeting the TGF beta signaling network in human neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN031